Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Moreno

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
European Journal of Gastroenterology & Hepatology|June 8, 2015
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trialsPierre Deltenre, Eric Trépo, Marika Rudler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2014
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide studyThierry Gustot, Peter Felleiter, Peter Pickkers, et al.
Journal of Hepatology|March 11, 2018
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitisThomas Sersté, Alexia Cornillie, Hassane Njimi, et al.
Gastrointestinal Endoscopy|December 6, 2011
Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcomePietro Familiari, Guido Costamagna, Daniel Bléro, et al.
Virology Journal|January 31, 2018
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infectionFabien Zoulim, Christophe Moreno, Samuel S Lee, et al.
Gastroenterology|August 7, 2012
Predicted effects of treatment for HCV infection vary among European countriesSylvie Deuffic-Burban, Pierre Deltenre, Maria Buti, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
The interleukin-17 pathway is involved in human alcoholic liver diseaseArnaud Lemmers, Christophe Moreno, Thierry Gustot, et al.
Antiviral Therapy|October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trialMichael Manns, Henk Reesink, Thomas Berg, et al.
Acta Gastro-Enterologica Belgica|August 9, 2012
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitorsHans Orlent, Pierre Deltenre, Sven Francque, et al.
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
European Journal of Gastroenterology & Hepatology|June 8, 2015
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trialsPierre Deltenre, Eric Trépo, Marika Rudler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2014
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide studyThierry Gustot, Peter Felleiter, Peter Pickkers, et al.
Journal of Hepatology|March 11, 2018
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitisThomas Sersté, Alexia Cornillie, Hassane Njimi, et al.
Gastrointestinal Endoscopy|December 6, 2011
Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcomePietro Familiari, Guido Costamagna, Daniel Bléro, et al.
Virology Journal|January 31, 2018
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infectionFabien Zoulim, Christophe Moreno, Samuel S Lee, et al.
Gastroenterology|August 7, 2012
Predicted effects of treatment for HCV infection vary among European countriesSylvie Deuffic-Burban, Pierre Deltenre, Maria Buti, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
The interleukin-17 pathway is involved in human alcoholic liver diseaseArnaud Lemmers, Christophe Moreno, Thierry Gustot, et al.
Antiviral Therapy|October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trialMichael Manns, Henk Reesink, Thomas Berg, et al.
Acta Gastro-Enterologica Belgica|August 9, 2012
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitorsHans Orlent, Pierre Deltenre, Sven Francque, et al.
Pageof 20